Provided by Tiger Fintech (Singapore) Pte. Ltd.

PepGen Inc.

1.59
+0.12008.16%
Post-market: 1.52-0.0697-4.38%16:09 EDT
Volume:294.01K
Turnover:451.18K
Market Cap:51.98M
PE:-0.56
High:1.60
Open:1.52
Low:1.48
Close:1.47
Loading ...

Sell Rating on PepGen Inc. Amid Clinical and Regulatory Challenges

TIPRANKS
·
25 Feb

Sector Update: Health Care Stocks Advance Late Afternoon

MT Newswires Live
·
25 Feb

Top Midday Gainers

MT Newswires Live
·
25 Feb

PepGen Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
25 Feb

PepGen data ‘very encouraging’ for program, says H.C. Wainwright

TIPRANKS
·
25 Feb

PepGen initial DM1 data ‘a clear win,’ says Stifel

TIPRANKS
·
24 Feb

PepGen Inc. Announces Positive FREEDOM-DM1 Trial Results

TIPRANKS
·
24 Feb

BRIEF-PepGen Q4 Operating Expenses USD 24.345 Million

Reuters
·
24 Feb

PepGen Q4 Operating Income USD -24.345 Million

THOMSON REUTERS
·
24 Feb

PepGen Inc - Q4 Loss per Share $0.68

THOMSON REUTERS
·
24 Feb

Press Release: PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights

Dow Jones
·
24 Feb

PepGen Inc - Results From Freedom 15 Mg/Kg Cohort Expected in H2 2025

THOMSON REUTERS
·
24 Feb

PepGen Inc - Mean Splicing Correction of 29.1% at 10 Mg/Kg Dose

THOMSON REUTERS
·
24 Feb

PepGen Announces Positive Initial Results, Including Robust Splicing Correction, From Ongoing Freedom-Dm1 Trial in Patients With Dm1

THOMSON REUTERS
·
24 Feb

PepGen Inc - Pgn-Edodm1 Shows Favorable Emerging Safety Profile

THOMSON REUTERS
·
24 Feb

PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1

Business Wire
·
24 Feb

Analysts Offer Insights on Healthcare Companies: Pro Medicus Limited (OtherPMCUF), PepGen Inc. (PEPG) and Idexx Laboratories (IDXX)

TIPRANKS
·
04 Feb

PepGen price target lowered to $16 from $26 at H.C. Wainwright

TIPRANKS
·
30 Jan

PepGen Inc. (PEPG) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
30 Jan

PepGen Inc : H.c. Wainwright Cuts Target Price to $16 From $26

THOMSON REUTERS
·
30 Jan